Kailera Therapeutics is trading 11.39% down now at $16.42 as broad biotech-sector selling intensified ahead of Federal Reserve Chair Kevin Warsh’s Jackson Hole speech.
- Biotech ETF XBI is down 2.31%, reflecting rate-sensitive investors rotating away from higher-risk growth stocks.
- No company-specific announcement dated August 28, 2026, was identified; the latest official release was August 12, covering second-quarter results and pipeline updates.